Article and Video CATEGORIES

Cancer Journey

Search By

Lyudmila A. Bazhenova, MD, is a board-certified medical oncologist. Her clinical practice is devoted to patients with all types of lung cancer, and she has particular expertise with female patients and nonsmokers. She believes in a multidisciplinary approach to lung cancer, and works closely with surgical oncologists and radiation oncologists to provide the best patient experience.

She leads a weekly "lung tumor board," where expert physicians and scientists from several specialties review cases to develop the best possible individualized treatment plan.

Lung Cancer Onctalk 2023 - Dr. Lyudmila Bazhenova
AlexandraGBeneke
A recorded live event where a team of top oncologists discusses emerging concepts and best practices in non-small cell lung cancer (NSCLC).
Author
Lyudmila Bazhenova MD - Guest Faculty
Image
Lung Cancer OncTalk 2023

At our live event, Lung Cancer OncTalk 2023, Lyudmila Bazhenova talks about Antibody Drug Conjugates, Toxicities in Antibody Drug Conjugate Treatment, and Bispecific Antibodies in Lung Cancer. 

To watch the complete playlist click here.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

A Brief Tornado.  I love the analogy Dr. Antonoff gave us to describe her presentation.  I felt it earlier too and am looking forward to going back for deeper dive.

Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".

While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".  

I hope any...

My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...

The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)

There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...

Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.

The...

Recent Comments

JOIN THE CONVERSATION
My understanding of ADCs is…
By JanineT GRACE … on
Right patient, right time,…
By JanineT GRACE … on
A Brief Tornado.  I love the…
By JanineT GRACE … on
Biomarkers
By JanineT GRACE … on